Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Suraksha Diagnostic Ltd. ( (IN:SURAKSHA) ) has issued an update.
Suraksha Diagnostic Limited has announced that Group Chief Financial Officer and Key Managerial Personnel K S Ravindra has tendered his resignation, which was received by the company on 2 March 2026. His last working day will be on or before 31 May 2026, and the board has formally recorded its appreciation for his services during his tenure.
The company stated that Ravindra has confirmed there are no material reasons for his resignation beyond those cited in his letter, aiming to reassure investors and regulators about the nature of the leadership change. The disclosure has been made in line with SEBI’s listing regulations, underscoring the company’s adherence to corporate governance norms as it manages this transition in its finance leadership.
More about Suraksha Diagnostic Ltd.
Suraksha Diagnostic Limited is an India-based healthcare services company operating in the diagnostics sector. It provides pathology and radiology testing services, with a presence anchored in Kolkata, West Bengal, and serves patients through a network focused on medical diagnostic solutions across its regional markets.
Average Trading Volume: 1,172
Technical Sentiment Signal: Strong Sell
Current Market Cap: 14.14B INR
For detailed information about SURAKSHA stock, go to TipRanks’ Stock Analysis page.